MedTrace Logo

Complete Infarct Related Artery Revascularization

NCT01218815 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2015-03-06

No results posted yet for this study

Summary

CORAMI trial is a prospective, international, multicenter randomized study which will be performed in experienced invasive facility centres with 24/7 PCI (percutaneous coronary intervention) duty and patient enrollment will continue for 18 months (October 2010 - March 2012).The aim of the study is to compare strategy of complete vs target lesion-only primary PCI in IRA (infarct related artery) in STEMI (ST elevation myocardial infarction) patients.

Conditions

Interventions

PROCEDURE

IRA stenting in culprit lesion only

stenting

PROCEDURE

IRA stenting

Complete IRA revascularization

Sponsors & Collaborators

  • Fundacja Ośrodek Badań Medycznych

    lead OTHER

Principal Investigators

  • Dariusz Dudek, MD, PhD · Department of Interventional Cardiology, Jagiellonian University Medical College in Krakow, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Poland
  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01218815 on ClinicalTrials.gov